Aspects of QoL are particularly important for the acceptance and thereby the implementation of diagnostic and therapeutic procedures in women with GDM (e.g., intensified insulin treatment—fear of hypoglycemia or fetal impairment), because they could reduce the women’s adherence via an adverse effect on QoL despite proven treatment efficacy. Here, INS is linked to gestational diabetes.